Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heme oxygenase and atherosclerosis.

Toshisuke Morita1

  • 1Department of Laboratory Medicine, Toho University School of Medicine, Tokyo, 143-8540, Japan. toshimrt@med.toho-u.ac.jp

Arteriosclerosis, Thrombosis, and Vascular Biology
|July 16, 2005
PubMed
Summary

Heme oxygenase-1 (HO-1) combats oxidative stress in cardiovascular diseases (CVD) by degrading heme and producing antioxidant compounds. HO-1 shows therapeutic potential for treating CVD, including atherosclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of cerebrospinal fluid presepsin (soluble CD14 subtype) as a new marker in the diagnosis of neurosurgical postoperative meningitis.

Frontiers in neurology·2024
Same author

Urinary excretion of thyroid hormone in CKD patients: a proof-of-concept of nephrogenic hypothyroidism.

Renal failure·2023
Same author

Comparative analysis on characteristics of two activated partial thromboplastin time reagents.

Journal of clinical laboratory analysis·2022
Same author

Molecular and biochemical characterization of novel PAM-like MBL variants, PAM-2 and PAM-3, from clinical isolates of Pseudomonas tohonis.

The Journal of antimicrobial chemotherapy·2022
Same author

Quantitative evaluation of insulin-induced abdominal subcutaneous dystrophic tissue using shear wave elastography.

Journal of diabetes investigation·2022
Same author

<i>Pseudomonas tohonis</i> sp. nov., isolated from the skin of a patient with burn wounds in Japan.

International journal of systematic and evolutionary microbiology·2021

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Reactive oxygen species (ROS) overproduction drives cardiovascular diseases (CVD) like atherosclerosis.
  • Vascular cell-derived ROS regulate inflammatory and antioxidative pathways.
  • Heme oxygenase (HO) is a stress-induced enzyme crucial for heme catabolism.

Purpose of the Study:

  • To explore the role of heme oxygenase (HO) and its inducible form (HO-1) in cardiovascular disease.
  • To review gene-targeting strategies in animal models related to HO-1.
  • To assess the therapeutic potential and challenges of targeting HO-1 for CVD.

Main Methods:

  • Literature review on heme oxygenase and cardiovascular disease.
  • Analysis of studies involving gene-targeting approaches in animal models.

Related Experiment Videos

  • Examination of the biochemical mechanisms of HO-1 cytoprotective effects.

    • Main Results:

    • HO-1 degrades pro-oxidative heme, producing antioxidant biliverdin/bilirubin and anti-inflammatory carbon monoxide.
    • HO-1 products exhibit antioxidant, anti-inflammatory, and vasodilatory properties.
    • Evidence suggests HO-1 plays a protective role against oxidative stress in CVD.

    Conclusions:

    • Heme oxygenase-1 (HO-1) is a key adaptive molecule against oxidative stress in cardiovascular diseases.
    • HO-1's cytoprotective mechanisms involve heme degradation and product generation.
    • HO-1 presents a promising therapeutic target for cardiovascular diseases, particularly atherosclerosis.